Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Curent Deferred Tax Liability: 2014-2015

Historic Curent Deferred Tax Liability for Amphastar Pharmaceuticals (AMPH) over the last 1 years, with Sep 2015 value amounting to $161,000.

  • Amphastar Pharmaceuticals' Curent Deferred Tax Liability fell 79.80% to $161,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $161,000, marking a year-over-year decrease of 79.80%. This contributed to the annual value of $1.2 million for FY2014, which is N/A change from last year.
  • Amphastar Pharmaceuticals' Curent Deferred Tax Liability amounted to $161,000 in Q3 2015, which was up 1.26% from $159,000 recorded in Q2 2015.
  • Over the past 5 years, Amphastar Pharmaceuticals' Curent Deferred Tax Liability peaked at $1.2 million during Q4 2014, and registered a low of $156,000 during Q1 2015.
  • Its 2-year average for Curent Deferred Tax Liability is $493,200, with a median of $161,000 in 2015.
  • Data for Amphastar Pharmaceuticals' Curent Deferred Tax Liability shows a maximum YoY tumbled of 79.80% (in 2015) over the last 5 years.
  • Over the past 2 years, Amphastar Pharmaceuticals' Curent Deferred Tax Liability (Quarterly) stood at $1.2 million in 2014, then slumped by 79.80% to $161,000 in 2015.
  • Its Curent Deferred Tax Liability stands at $161,000 for Q3 2015, versus $159,000 for Q2 2015 and $156,000 for Q1 2015.